Search for: "State v. G. N." Results 2321 - 2340 of 2,538
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
6 Oct 2022, 12:51 am by Florian Mueller
There are three paragraphs that stress the "central objective of CADE's efforts" ("o objetivo central da atuação do Cade"), which is that of every competition authority in the civilized world: to protect, in the interest of consumer welfare, the competitive process ("concorrência") (as the United States Court of Appeals for the Ninth Circuit also emphasized in its FTC v. [read post]
13 Sep 2011, 3:02 pm by SteinMcewen, LLP
Smith (R-TX) on March 30, 2011, the first significant change to the United States patent system has arrived. [read post]
24 Dec 2022, 6:50 pm by Bill Marler
Even after the Court’s twisted opinion in Supreme Beef v. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]